Protalix BioTherapeutics Inc (PLX)
1.76
+0.02
(+1.15%)
USD |
NYAM |
Dec 20, 16:00
1.755
0.00 (0.00%)
Pre-Market: 20:00
Protalix BioTherapeutics Shareholders Equity (Quarterly): 32.44M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Accuray Inc | 45.22M |
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 61.56M |
| Total Liabilities (Quarterly) | 29.13M |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | 5.36% |